RxDoctor Payments Data

Emily Lampshire, NP

Adult Health · New York, NYNPI 1912446790

Payments from drug & device makers

$6,093in general payments, 2019–2025

Across 120 payments — averaging $50.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • AbbVie$877
  • Teva Pharmaceuticals USA, Inc.$773
  • Biohaven Pharmaceutical Holding Company Ltd.$401
  • Pfizer$319
  • Eisai Inc.$139
  • plus $61 from 3 others

What the payments were for

  • Consulting fees$3,50057%
  • Food & beverage$2,59343%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,093 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$45,403
Medicare patients
196
Services billed
3,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RebifInterferon Beta-1a/Albumin12$121,552
OctagamImmun Globg(Igg)/Malt/Iga Ov5012$102,476
BotoxOnabotulinumtoxina23$28,676
Nurtec OdtRimegepant Sulfate16$23,464
Glatiramer Acetate11$15,537
Lidocaine74$11,745
LyricaPregabalin11$6,577
Gabapentin155$4,626
Pregabalin102$2,452
Duloxetine Hcl47$1,046
Oxcarbazepine18$765
Pyridostigmine Bromide14$536
Lamotrigine20$416
Levetiracetam16$404
RizatriptanRizatriptan Benzoate11$316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerOctagam, Nurtec Odt, Lyrica$319$132,51739 claims
AbbVieBotox$877$28,67623 claims
Upsher-smith Laboratories LLCTopiramate$18$9617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,828 adult health providers in New York.

Other adult health in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →